197 related articles for article (PubMed ID: 9351876)
1. Comparison of assay of total and bone-specific alkaline phosphatase in the assessment of osteoblast activity in patients with metastatic bone disease.
Piovesan A; Berruti A; Torta M; Cannone R; Sperone P; Panero A; Gorzegno G; Termine A; Dogliotti L; Angeli A
Calcif Tissue Int; 1997 Nov; 61(5):362-9. PubMed ID: 9351876
[TBL] [Abstract][Full Text] [Related]
2. Serum alkaline phosphatase isoenzyme activities in canine malignant mammary neoplasms with and without osseous transformation.
Karayannopoulou M; Polizopoulou ZS; Koutinas AF; Fytianou A; Roubies N; Kaldrymidou E; Tsioli V; Patsikas MN; Constantinidis TC; Koutinas CK
Vet Clin Pathol; 2006 Sep; 35(3):287-90. PubMed ID: 16967410
[TBL] [Abstract][Full Text] [Related]
3. Biochemical evaluation of bone turnover in cancer patients with bone metastases: relationship with radiograph appearances and disease extension.
Berruti A; Piovesan A; Torta M; Raucci CA; Gorzegno G; Paccotti P; Dogliotti L; Angeli A
Br J Cancer; 1996 Jun; 73(12):1581-7. PubMed ID: 8664134
[TBL] [Abstract][Full Text] [Related]
4. Procollagen type I carboxy-terminal propeptide as a marker of osteoblastic bone metastases.
Francini G; Gonnelli S; Petrioli R; Bruni S; Marsili S; Aquino A; Camporeale A
Cancer Epidemiol Biomarkers Prev; 1993; 2(2):125-9. PubMed ID: 8467247
[TBL] [Abstract][Full Text] [Related]
5. Biochemical picture of bone metabolism in breast cancer patients with bone metastases.
Berruti A; Torta M; Piovesan A; Raucci CA; Orlandi F; Panero A; Dogliotti L; Angeli A
Anticancer Res; 1995; 15(6B):2871-5. PubMed ID: 8669881
[TBL] [Abstract][Full Text] [Related]
6. Comparison of bone scintigraphy with bone markers in the diagnosis of bone metastasis in lung carcinoma patients.
Ebert W; Muley T; Herb KP; Schmidt-Gayk H
Anticancer Res; 2004; 24(5B):3193-201. PubMed ID: 15510610
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of serum alkaline phosphatase activity in canine appendicular osteosarcoma.
Garzotto CK; Berg J; Hoffmann WE; Rand WM
J Vet Intern Med; 2000; 14(6):587-92. PubMed ID: 11110379
[TBL] [Abstract][Full Text] [Related]
8. The bone isoenzyme of alkaline phosphatase in hypercalcaemic cancer patients.
Body JJ; Dumon JC; Blocklet D; Darte C
Eur J Cancer; 1997 Sep; 33(10):1578-82. PubMed ID: 9389918
[TBL] [Abstract][Full Text] [Related]
9. Transient increase in total serum alkaline phosphatase predicts radiological response to systemic therapy in breast cancer patients with osteolytic and mixed bone metastases.
Berruti A; Osella G; Raucci CA; Roncari A; Dogliotti L
Oncology; 1993; 50(4):218-21. PubMed ID: 8497373
[TBL] [Abstract][Full Text] [Related]
10. Pamidronate administration improves the secondary hyperparathyroidism due to "Bone Hunger Syndrome" in a patient with osteoblastic metastases from prostate cancer.
Berruti A; Sperone P; Fasolis G; Torta M; Fontana D; Dogliotti L; Angeli A
Prostate; 1997 Dec; 33(4):252-5. PubMed ID: 9397197
[TBL] [Abstract][Full Text] [Related]
11. The age dependent levels of serum ALP isoenzymes and the diagnostic significance of corticosteroid-induced ALP during long-term glucocorticoid treatment.
Syakalima M; Takiguchi M; Yasuda J; Hashimoto A
J Vet Med Sci; 1997 Oct; 59(10):905-9. PubMed ID: 9362039
[TBL] [Abstract][Full Text] [Related]
12. Biochemical prediction of response of bone metastases to treatment.
Coleman RE; Whitaker KB; Moss DW; Mashiter G; Fogelman I; Rubens RD
Br J Cancer; 1988 Aug; 58(2):205-10. PubMed ID: 3262366
[TBL] [Abstract][Full Text] [Related]
13. New and traditional serum markers of bone metabolism in the detection of skeletal metastases.
Plebani M; Bernardi D; Zaninotto M; De Paoli M; Secchiero S; Sciacovelli L
Clin Biochem; 1996 Feb; 29(1):67-72. PubMed ID: 8929827
[TBL] [Abstract][Full Text] [Related]
14. Serum levels of bone Gla protein (osteocalcin, BGP) and carboxyterminal propeptide of type I procollagen (PICP) in acromegaly: effects of long-term octreotide treatment.
Terzolo M; Piovesan A; Osella G; Pia A; Reimondo G; Pozzi C; Raucci C; Torta M; Paccotti P; Angeli A
Calcif Tissue Int; 1993 Mar; 52(3):188-91. PubMed ID: 8481830
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of bone-specific alkaline phosphatase and procollagen type I carboxyterminal peptide in vitamin D deficiency.
Nawawi H; Girgis SI
Southeast Asian J Trop Med Public Health; 2002; 33 Suppl 2():124-30. PubMed ID: 12755282
[TBL] [Abstract][Full Text] [Related]
16. Metabolic effects of single-dose pamidronate administration in prostate cancer patients with bone metastases.
Berruti A; Dogliotti L; Tucci M; Tarabuzzi R; Guercio S; Torta M; Tampellini M; Dovio A; Poggio M; Scarpa RM; Angeli A
Int J Biol Markers; 2002; 17(4):244-52. PubMed ID: 12521128
[TBL] [Abstract][Full Text] [Related]
17. Age related changes in biochemical markers of bone metabolism in horses.
Price JS; Jackson B; Eastell R; Goodship AE; Blumsohn A; Wright I; Stoneham S; Lanyon LE; Russell RG
Equine Vet J; 1995 May; 27(3):201-7. PubMed ID: 7556047
[TBL] [Abstract][Full Text] [Related]
18. Clinical usefulness of serum carboxyterminal propeptide of procollagen I and tartrate-resistant acid phosphatase determinations to evaluate bone turnover in patients with chronic renal failure.
López Gavilanes E; González Parra E; de la Piedra C; Caramelo C; Rapado A
Miner Electrolyte Metab; 1994; 20(5):259-64. PubMed ID: 7700213
[TBL] [Abstract][Full Text] [Related]
19. Comparison of serum osteocalcin with total and bone specific alkaline phosphatase and urinary hydroxyproline:creatinine ratio in patients with Paget's disease of bone.
Kaddam IM; Iqbal SJ; Holland S; Wong M; Manning D
Ann Clin Biochem; 1994 Jul; 31 ( Pt 4)():327-30. PubMed ID: 7979096
[TBL] [Abstract][Full Text] [Related]
20. Bone turnover in hyperthyroidism before and after thyrostatic management.
Isaia GC; Roggia C; Gola D; Stefano MD; Gallone G; Aimo G; Ardissone P; Mussetta M
J Endocrinol Invest; 2000 Dec; 23(11):727-31. PubMed ID: 11194705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]